I think the hypothetical question here is: if someone was offered 20 -30 dollars per share right now, would they take it?
that's 5-8 times the SP now. I believe most would say yes(personal opinion), despite what the board would suggest. That is a massive increase in someone's investment and not common in most instances.
I feel the board has an intrinsic value in their minds, and it's closer to the value of keytruda than it is magrolimab(forty seven).
my opinion: they've done the in depth research into how high a chance this will translate from pre clinical to humans. I reckon they believe based on the science that this is high. Their biggest risk is designing the trial, although I feel this may be easier than trying to prove something over standard of care, as to get a patient or doctor to try something over the well known treatment is quite difficult. I may be completely out of my depth with this assumption, and if so I hope someone can correct me.
- Forums
- ASX - By Stock
- RAC
- Ann: Change in substantial holding
Ann: Change in substantial holding, page-121
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.88 |
Change
-0.060(3.09%) |
Mkt cap ! $326.2M |
Open | High | Low | Value | Volume |
$1.93 | $1.97 | $1.87 | $285.1K | 148.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | $1.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.89 | 7207 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | 1.870 |
1 | 900 | 1.860 |
3 | 2412 | 1.855 |
7 | 8357 | 1.850 |
1 | 3804 | 1.840 |
Price($) | Vol. | No. |
---|---|---|
1.890 | 7207 | 3 |
1.895 | 1393 | 2 |
1.900 | 2800 | 2 |
1.905 | 229 | 1 |
1.910 | 2941 | 1 |
Last trade - 14.25pm 16/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |